Article
Interleukin-2 mutants with enhanced alpha-receptor subunit binding affinity.
Protein engineering - 1 Dec 2003
Rao Balaji M, Girvin Andrew T, Ciardelli Thomas, Lauffenburger Douglas A, Wittrup K Dane
Abstract excerpt
Stimulation of T-cells by IL-2 has been exploited for treatment of metastatic renal carcinoma and melanoma. However, a narrow therapeutic window delimited by negligible stimulation of T-cells at low picomolar concentrations and undesirable stimulation of NK cells at nanomolar concentrations hampers IL-2-based therapies. We hypothesized that increasing the affinity of IL-2 for IL-2Ralpha may create a class of IL-2...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
